{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-10145"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-10145","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"A Micro-Nano Particle System for Sustained Drug Release in Lung Cancer Therapy","abstract":"Lung cancer remains the leading cause of cancer-related mortality in men and women worldwide (National Comprehensive Cancer Network). Hence, developing an effective new therapy to treat lung cancer is under intense investigation. Specifically, the sustained release of a drug in lung tumors is critically important. Previous studies at the USF have shown that telmisartan exhibits synergistic properties when combined with Actinomycin-D for lung cancer treatment. The objective of this study is to develop a novel micro/nano system consisting of lipids and chitosan polymers that would be able to deliver Tel directly to the lungs and release its payloads in a targeted and controlled way. To achieve this, in this study we report the synthesis and in vitro characterization of a novel nano-in-micro platform. First, telmisartan is entrapped in chitosan for sustained drug release. For this purpose, Telmisartan-loaded tri-poly phosphate (TPP)- crosslinked chitosan NPs are loaded onto liposomal microparticles for effective lung accumulation. The size and morphology of this micro/nano-system were characterized via DLS and TEM. The size distribution and zeta potential of telmisartan loaded chitosan-TPP nanoparticle was found to be 160 ± 5 nm with PDI 0.1 ± 0.05 and 20mV, respectively. The encapsulation of telmisartan into chitosan-TPP nanoparticle was 100 %. The chitosan-TPP nanoparticle showed sustained release of telmisartan. In-vivo studies demonstrated a high accumulation of this micro/nano-system in the lungs after intravenous administration. Taken together, these results indicate that micro-in nanoparticles permit sustained release of telmisartan.","abstract_html":"Lung cancer remains the leading cause of cancer-related mortality in men and women worldwide (National Comprehensive Cancer Network). Hence, developing an effective new therapy to treat lung cancer is under intense investigation. Specifically, the sustained release of a drug in lung tumors is critically important. Previous studies at the USF have shown that telmisartan exhibits synergistic properties when combined with Actinomycin-D for lung cancer treatment. The objective of this study is to develop a novel micro/nano system consisting of lipids and chitosan polymers that would be able to deliver Tel directly to the lungs and release its payloads in a targeted and controlled way. To achieve this, in this study we report the synthesis and in vitro characterization of a novel nano-in-micro platform. First, telmisartan is entrapped in chitosan for sustained drug release. For this purpose, Telmisartan-loaded tri-poly phosphate (TPP)- crosslinked chitosan NPs are loaded onto liposomal microparticles for effective lung accumulation. The size and morphology of this micro/nano-system were characterized via DLS and TEM. The size distribution and zeta potential of telmisartan loaded chitosan-TPP nanoparticle was found to be 160 ± 5 nm with PDI 0.1 ± 0.05 and 20mV, respectively. The encapsulation of telmisartan into chitosan-TPP nanoparticle was 100 %. The chitosan-TPP nanoparticle showed sustained release of telmisartan. In-vivo studies demonstrated a high accumulation of this micro/nano-system in the lungs after intravenous administration. Taken together, these results indicate that micro-in nanoparticles permit sustained release of telmisartan.","abstract_has_math":false,"creators":["Jadhav, Heta N."],"institution":"University of South Florida","degree_name":"Master of Science (M.S.)","degree_level":"Thesis","degree_discipline":"Graduate School","degree_department":null,"school":null,"contributors":["Shyam Mohapatra, Ph.D.","Subhra Mohapatra, Ph.D.","Eleni Markoutsa, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2020,"date_issued":"2020-03-20T07:00:00Z","date_published":"2020-03-20T07:00:00Z","updated_at":"2026-11-19T08:46:56Z","subjects":["Lung Cancer","Microparticle","Nanoparticle","Sustained release","Telmisartan","Medicinal Chemistry and Pharmaceutics","Nanoscience and Nanotechnology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/8948","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/8948","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-10145","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Shyam Mohapatra, Ph.D.","Subhra Mohapatra, Ph.D.","Eleni Markoutsa, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Jadhav, Heta N."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2020-03-20T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Graduate School"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis","M.S."]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (M.S.)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Lung Cancer","Microparticle","Nanoparticle","Sustained release","Telmisartan","Medicinal Chemistry and Pharmaceutics","Nanoscience and Nanotechnology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/8948"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Lung cancer remains the leading cause of cancer-related mortality in men and women worldwide (National Comprehensive Cancer Network). Hence, developing an effective new therapy to treat lung cancer is under intense investigation. Specifically, the sustained release of a drug in lung tumors is critically important. Previous studies at the USF have shown that telmisartan exhibits synergistic properties when combined with Actinomycin-D for lung cancer treatment. The objective of this study is to develop a novel micro/nano system consisting of lipids and chitosan polymers that would be able to deliver Tel directly to the lungs and release its payloads in a targeted and controlled way. To achieve this, in this study we report the synthesis and in vitro characterization of a novel nano-in-micro platform. First, telmisartan is entrapped in chitosan for sustained drug release. For this purpose, Telmisartan-loaded tri-poly phosphate (TPP)- crosslinked chitosan NPs are loaded onto liposomal microparticles for effective lung accumulation. The size and morphology of this micro/nano-system were characterized via DLS and TEM. The size distribution and zeta potential of telmisartan loaded chitosan-TPP nanoparticle was found to be 160 ± 5 nm with PDI 0.1 ± 0.05 and 20mV, respectively. The encapsulation of telmisartan into chitosan-TPP nanoparticle was 100 %. The chitosan-TPP nanoparticle showed sustained release of telmisartan. In-vivo studies demonstrated a high accumulation of this micro/nano-system in the lungs after intravenous administration. Taken together, these results indicate that micro-in nanoparticles permit sustained release of telmisartan."]},{"key":"dc:title","label":"Title","values":["A Micro-Nano Particle System for Sustained Drug Release in Lung Cancer Therapy"]}]}],"canonical_facts":{"dc:contributor":["Shyam Mohapatra, Ph.D.","Subhra Mohapatra, Ph.D.","Eleni Markoutsa, Ph.D."],"dc:creator":["Jadhav, Heta N."],"dc:date":["2020-03-20T07:00:00Z"],"dc:description":["Lung cancer remains the leading cause of cancer-related mortality in men and women worldwide (National Comprehensive Cancer Network). Hence, developing an effective new therapy to treat lung cancer is under intense investigation. Specifically, the sustained release of a drug in lung tumors is critically important. Previous studies at the USF have shown that telmisartan exhibits synergistic properties when combined with Actinomycin-D for lung cancer treatment. The objective of this study is to develop a novel micro/nano system consisting of lipids and chitosan polymers that would be able to deliver Tel directly to the lungs and release its payloads in a targeted and controlled way. To achieve this, in this study we report the synthesis and in vitro characterization of a novel nano-in-micro platform. First, telmisartan is entrapped in chitosan for sustained drug release. For this purpose, Telmisartan-loaded tri-poly phosphate (TPP)- crosslinked chitosan NPs are loaded onto liposomal microparticles for effective lung accumulation. The size and morphology of this micro/nano-system were characterized via DLS and TEM. The size distribution and zeta potential of telmisartan loaded chitosan-TPP nanoparticle was found to be 160 ± 5 nm with PDI 0.1 ± 0.05 and 20mV, respectively. The encapsulation of telmisartan into chitosan-TPP nanoparticle was 100 %. The chitosan-TPP nanoparticle showed sustained release of telmisartan. In-vivo studies demonstrated a high accumulation of this micro/nano-system in the lungs after intravenous administration. Taken together, these results indicate that micro-in nanoparticles permit sustained release of telmisartan."],"dc:identifier":["https://digitalcommons.usf.edu/etd/8948"],"dc:subject":["Lung Cancer","Microparticle","Nanoparticle","Sustained release","Telmisartan","Medicinal Chemistry and Pharmaceutics","Nanoscience and Nanotechnology"],"dc:title":["A Micro-Nano Particle System for Sustained Drug Release in Lung Cancer Therapy"],"thesis:degree_discipline":["Graduate School"],"thesis:degree_level":["Thesis","M.S."],"thesis:degree_name":["Master of Science (M.S.)"],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:46:56Z"}